Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.40p
   
  • Change Today:
    -0.050p
  • 52 Week High: 8.25
  • 52 Week Low: 1.73
  • Currency: UK Pounds
  • Shares Issued: 561.38m
  • Volume: 370,048
  • Market Cap: £30.31m
  • RiskGrade: 348

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

Key Personnel

CEO: James Renwick McCullough
Chief Technical Officer: Fergus Fleming
Non-Executive Chairman: Christopher H B Mills
Non-Executive Dir: Erik Kristian Lium, Catherine Coste, Robert (Rob) Graham Naylor

Contact Details

Address: 2 Leman Street, London, United Kingdom, E1W 9US
Website: http://www.renalytix.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYWL4Y04

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 5.40p
Change Today -0.050p
% Change -0.92 %
52 Week High 8.25
52 Week Low 1.73
Volume 370,048
Shares Issued 561.38m
Market Cap £30.31m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.49% above the market average34.49% above the market average34.49% above the market average34.49% above the market average34.49% above the market average
36.59% above the sector average36.59% above the sector average36.59% above the sector average36.59% above the sector average36.59% above the sector average
Price Trend
95.29% below the market average95.29% below the market average95.29% below the market average95.29% below the market average95.29% below the market average
76.74% below the sector average76.74% below the sector average76.74% below the sector average76.74% below the sector average76.74% below the sector average
Income Not Available
Growth
1.43% above the market average1.43% above the market average1.43% above the market average1.43% above the market average1.43% above the market average
21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average

RENX Dividends

No dividends found

Trades for 30-Oct-2026

Time Volume / Share Price
11:22 16,000 @ 5.38p
10:47 20,000 @ 5.38p
08:12 150,000 @ 5.36p
08:07 1,060 @ 5.50p
08:04 171 @ 5.50p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page